318 related articles for article (PubMed ID: 16282488)
1. CD8+ and CD20+ lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype.
Mao H; Lafont BA; Igarashi T; Nishimura Y; Brown C; Hirsch V; Buckler-White A; Sadjadpour R; Martin MA
J Virol; 2005 Dec; 79(23):14887-98. PubMed ID: 16282488
[TBL] [Abstract][Full Text] [Related]
2. Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.
Endo Y; Igarashi T; Nishimura Y; Buckler C; Buckler-White A; Plishka R; Dimitrov DS; Martin MA
J Virol; 2000 Aug; 74(15):6935-45. PubMed ID: 10888632
[TBL] [Abstract][Full Text] [Related]
3. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
4. Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses.
Nishimura Y; Igarashi T; Donau OK; Buckler-White A; Buckler C; Lafont BA; Goeken RM; Goldstein S; Hirsch VM; Martin MA
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12324-9. PubMed ID: 15297611
[TBL] [Abstract][Full Text] [Related]
5. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.
Voss G; Letvin NL
J Virol; 1996 Oct; 70(10):7335-40. PubMed ID: 8794394
[TBL] [Abstract][Full Text] [Related]
6. Emergence of a highly pathogenic simian/human immunodeficiency virus in a rhesus macaque treated with anti-CD8 mAb during a primary infection with a nonpathogenic virus.
Igarashi T; Endo Y; Englund G; Sadjadpour R; Matano T; Buckler C; Buckler-White A; Plishka R; Theodore T; Shibata R; Martin M
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14049-54. PubMed ID: 10570196
[TBL] [Abstract][Full Text] [Related]
7. Induction of disease by a molecularly cloned highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimera is multigenic.
Sadjadpour R; Theodore TS; Igarashi T; Donau OK; Plishka RJ; Buckler-White A; Martin MA
J Virol; 2004 May; 78(10):5513-9. PubMed ID: 15113931
[TBL] [Abstract][Full Text] [Related]
8. Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles.
Willey RL; Byrum R; Piatak M; Kim YB; Cho MW; Rossio JL; Bess J; Igarashi T; Endo Y; Arthur LO; Lifson JD; Martin MA
J Virol; 2003 Jan; 77(2):1163-74. PubMed ID: 12502833
[TBL] [Abstract][Full Text] [Related]
9. Although macrophage-tropic simian/human immunodeficiency viruses can exhibit a range of pathogenic phenotypes, a majority of isolates induce no clinical disease in immunocompetent macaques.
Igarashi T; Donau OK; Imamichi H; Nishimura Y; Theodore TS; Iyengar R; Erb C; Buckler-White A; Buckler CE; Martin MA
J Virol; 2007 Oct; 81(19):10669-79. PubMed ID: 17626082
[TBL] [Abstract][Full Text] [Related]
10. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).
Luciw PA; Pratt-Lowe E; Shaw KE; Levy JA; Cheng-Mayer C
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7490-4. PubMed ID: 7638218
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 envelope epitope-specific CD4(+) T lymphocytes in simian/human immunodeficiency virus-infected and vaccinated rhesus monkeys detected using a peptide-major histocompatibility complex class II tetramer.
Kuroda MJ; Schmitz JE; Lekutis C; Nickerson CE; Lifton MA; Franchini G; Harouse JM; Cheng-Mayer C; Letvin NL
J Virol; 2000 Sep; 74(18):8751-6. PubMed ID: 10954578
[TBL] [Abstract][Full Text] [Related]
12. Patterns of CD8+ immunodominance may influence the ability of Mamu-B*08-positive macaques to naturally control simian immunodeficiency virus SIVmac239 replication.
Loffredo JT; Bean AT; Beal DR; León EJ; May GE; Piaskowski SM; Furlott JR; Reed J; Musani SK; Rakasz EG; Friedrich TC; Wilson NA; Allison DB; Watkins DI
J Virol; 2008 Feb; 82(4):1723-38. PubMed ID: 18057253
[TBL] [Abstract][Full Text] [Related]
13. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
14. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
[TBL] [Abstract][Full Text] [Related]
15. The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys.
Igarashi T; Imamichi H; Brown CR; Hirsch VM; Martin MA
J Leukoc Biol; 2003 Nov; 74(5):772-80. PubMed ID: 14595005
[TBL] [Abstract][Full Text] [Related]
16. Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.
Igarashi T; Endo Y; Nishimura Y; Buckler C; Sadjadpour R; Donau OK; Dumaurier MJ; Plishka RJ; Buckler-White A; Martin MA
J Virol; 2003 Oct; 77(20):10829-40. PubMed ID: 14512533
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
[TBL] [Abstract][Full Text] [Related]
18. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys.
Reimann KA; Li JT; Voss G; Lekutis C; Tenner-Racz K; Racz P; Lin W; Montefiori DC; Lee-Parritz DE; Lu Y; Collman RG; Sodroski J; Letvin NL
J Virol; 1996 May; 70(5):3198-206. PubMed ID: 8627800
[TBL] [Abstract][Full Text] [Related]
19. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
[TBL] [Abstract][Full Text] [Related]
20. Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.
Hel Z; Nacsa J; Kelsall B; Tsai WP; Letvin N; Parks RW; Tryniszewska E; Picker L; Lewis MG; Edghill-Smith Y; Moniuszko M; Pal R; Stevceva L; Altman JD; Allen TM; Watkins D; Torres JV; Berzofsky JA; Belyakov IM; Strober W; Franchini G
J Virol; 2001 Dec; 75(23):11483-95. PubMed ID: 11689630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
